152 related articles for article (PubMed ID: 8282537)
1. Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function.
Schatz AR; Koh WS; Kaminski NE
Immunopharmacology; 1993; 26(2):129-37. PubMed ID: 8282537
[TBL] [Abstract][Full Text] [Related]
2. High concentrations of interleukin-2 selectively suppress T-cell dependent humoral immune responses.
Delaney B; Kaminski NE
Immunopharmacology; 1993; 26(2):119-27. PubMed ID: 8282536
[TBL] [Abstract][Full Text] [Related]
3. Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.
Lu H; Kaplan BL; Ngaotepprutaram T; Kaminski NE
J Leukoc Biol; 2009 Feb; 85(2):322-9. PubMed ID: 18988696
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the effects of direct alkylators on in vitro immune responses.
Haggerty HG; Kim BS; Holsapple MP
Mutat Res; 1990 Sep; 242(1):67-78. PubMed ID: 2392123
[TBL] [Abstract][Full Text] [Related]
5. Hyporesponsiveness to the immunosuppressant effects of delta-8-tetrahydrocannabinol.
Loveless SE; Harris LS; Munson AE
J Immunopharmacol; 1981-1982; 3(3-4):371-83. PubMed ID: 6290570
[TBL] [Abstract][Full Text] [Related]
6. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.
Kaminski NE; Koh WS; Yang KH; Lee M; Kessler FK
Biochem Pharmacol; 1994 Nov; 48(10):1899-908. PubMed ID: 7986201
[TBL] [Abstract][Full Text] [Related]
7. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
[TBL] [Abstract][Full Text] [Related]
8. Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators.
Pross SH; Nakano Y; Widen R; McHugh S; Newton CA; Klein TW; Friedman H
Int J Immunopharmacol; 1992 Aug; 14(6):1019-27. PubMed ID: 1330945
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1-thiocarbamoyl-2-imidazolidinone on the generation of plaque forming cell responses.
Sissors DL; Gautam SC; Webster LT
Int J Immunopharmacol; 1985; 7(2):177-85. PubMed ID: 3159691
[TBL] [Abstract][Full Text] [Related]
10. The role of metabolism in carbon tetrachloride-mediated immunosuppression. In vitro studies.
Kaminski NE; Stevens WD
Toxicology; 1992 Nov; 75(2):175-88. PubMed ID: 1462354
[TBL] [Abstract][Full Text] [Related]
11. Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo.
McKallip RJ; Lombard C; Martin BR; Nagarkatti M; Nagarkatti PS
J Pharmacol Exp Ther; 2002 Aug; 302(2):451-65. PubMed ID: 12130702
[TBL] [Abstract][Full Text] [Related]
12. The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses.
Klein TW; Newton CA; Widen R; Friedman H
J Immunopharmacol; 1985; 7(4):451-66. PubMed ID: 3003204
[TBL] [Abstract][Full Text] [Related]
13. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway.
Zhu LX; Sharma S; Stolina M; Gardner B; Roth MD; Tashkin DP; Dubinett SM
J Immunol; 2000 Jul; 165(1):373-80. PubMed ID: 10861074
[TBL] [Abstract][Full Text] [Related]
14. Effects of subchronic exposure to diethylstilbestrol on humoral immune function in adult female (C3B6)F1 mice.
Bick PH; Tucker AN; White KL; Holsapple MP
Immunopharmacology; 1984 Feb; 7(1):27-39. PubMed ID: 6538873
[TBL] [Abstract][Full Text] [Related]
15. Concentration-dependent bifunctional effect of TGF-beta 1 on immunoglobulin production: a role for Smad3 in IgA production in vitro.
McKarns SC; Letterio JJ; Kaminski NE
Int Immunopharmacol; 2003 Dec; 3(13-14):1761-74. PubMed ID: 14636827
[TBL] [Abstract][Full Text] [Related]
16. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD)-induced humoral immune suppression: evidence of primary defect in T-cell regulation.
Kerkvliet NI; Brauner JA
Toxicol Appl Pharmacol; 1987 Jan; 87(1):18-31. PubMed ID: 3492063
[TBL] [Abstract][Full Text] [Related]
18. A functional characterization of macrophage alterations in casein-treated B6C3F1 mice.
Kaminski NE; Holsapple MP
Immunopharmacology; 1992; 24(3):229-40. PubMed ID: 1478855
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition by intravenous immunoglobulin of human T cell-dependent B cell differentiation induced by staphylococcal superantigens.
Stohl W; Elliot JE
Clin Immunol Immunopathol; 1996 May; 79(2):122-33. PubMed ID: 8620618
[TBL] [Abstract][Full Text] [Related]
20. Assessment of tolerance to immunosuppressive activity of delta 9-tetrahydrocannabinol in rats.
Luthra YK; Esber HJ; Lariviere DM; Rosenkrantz H
J Immunopharmacol; 1980; 2(2):245-56. PubMed ID: 6101114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
